CTRI/2010/091/001068已完成3 期
A Double-blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or female patients who are 18 to 60 years of age
- •Patients who have provided informed consent prior to any study specific procedures
- •Patients currently meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for schizophrenia (paranoid type, disorganized type, catatonic type or undifferentiated type), as confirmed by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID)
- •Patients with normal physical examination, laboratory, vital signs,and/ or electrocardiogram (ECG)
排除标准
- •Patients with a DSM-IV-TR diagnosis of Schizoaffective disorder, schizophreniform disorder, other psychotic disorders other than schizophrenia, or bipolar I or II disorder
研究者
相似试验
进行中（未招募）
1 期
The purpose of this research study is to gather information about how safe, tolerable, and effective cariprazine is for patients with bipolar depression.Bipolar I Disorder Major Depressive EpisodeMedDRA version: 14.1Level: PTClassification code 10004939Term: Bipolar I disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-002334-39-BGForest Research Institute, Inc584
已完成
3 期
The purpose of this study is to determine whether cariprazine is safe and effective in the treatment of patients with acute mania associated with Bipolar I disorder.CTRI/2010/091/000140Forest Research Institute320
进行中（未招募）
2 期
In this study the effectiveness of a Hair tablet will be studied in women with thinning of hair.CTRI/2018/03/012868Atlantic Coast Brands
进行中（未招募）
1 期
A Double-Blind Placebo-Controlled Pilot Study of the Safety and Tolerability of AIMSPRO in established Diffuse Cutaneous Systemic Sclerosis - Pilot study of AIMSPRO in diffuse cutaneous systemic sclerosisEUCTR2007-003122-24-GBDaval International Limited20
进行中（未招募）
不适用
5% Topical Ibuprofen (IBU) for Ankle SpraiEUCTR2015-001874-16-Outside-EU/EEAPfizer304